Certara, Inc. (NASDAQ:CERT) Receives $20.06 Average Target Price from Brokerages

Shares of Certara, Inc. (NASDAQ:CERTGet Free Report) have received a consensus rating of “Hold” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $20.06.

A number of equities research analysts have weighed in on the stock. Jefferies Financial Group lifted their price target on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research note on Friday, March 1st. JMP Securities started coverage on shares of Certara in a research note on Thursday, April 4th. They issued a “market perform” rating on the stock. Leerink Partnrs restated a “market perform” rating on shares of Certara in a research note on Monday, February 26th. UBS Group upped their price objective on Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a research note on Friday, March 1st. Finally, KeyCorp raised Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a report on Wednesday, April 10th.

View Our Latest Research Report on Certara

Insider Buying and Selling at Certara

In related news, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the transaction, the insider now owns 50,091 shares in the company, valued at approximately $844,033.35. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total value of $54,000.00. Following the completion of the sale, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the transaction, the insider now directly owns 50,091 shares in the company, valued at approximately $844,033.35. The disclosure for this sale can be found here. Corporate insiders own 2.39% of the company’s stock.

Institutional Trading of Certara

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Pineridge Advisors LLC acquired a new position in Certara in the fourth quarter valued at approximately $28,000. Global Retirement Partners LLC raised its holdings in shares of Certara by 5,306.3% in the first quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock valued at $31,000 after purchasing an additional 1,698 shares during the last quarter. YHB Investment Advisors Inc. bought a new stake in shares of Certara in the first quarter worth $47,000. Covestor Ltd boosted its holdings in Certara by 14,940.0% during the third quarter. Covestor Ltd now owns 3,760 shares of the company’s stock worth $55,000 after purchasing an additional 3,735 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new position in Certara in the third quarter valued at $145,000. 73.96% of the stock is owned by institutional investors.

Certara Trading Up 1.2 %

Shares of CERT stock opened at $16.73 on Monday. The company has a current ratio of 3.26, a quick ratio of 3.26 and a debt-to-equity ratio of 0.27. Certara has a 1 year low of $11.81 and a 1 year high of $22.65. The firm’s fifty day simple moving average is $17.19 and its 200 day simple moving average is $16.74. The firm has a market capitalization of $2.69 billion, a P/E ratio of -42.90, a price-to-earnings-growth ratio of 5.72 and a beta of 1.61.

Certara (NASDAQ:CERTGet Free Report) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. The company had revenue of $88.01 million for the quarter, compared to analyst estimates of $86.80 million. As a group, sell-side analysts predict that Certara will post 0.29 EPS for the current year.

Certara Company Profile

(Get Free Report

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

Featured Articles

Analyst Recommendations for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.